rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-2-1
|
pubmed:databankReference |
|
pubmed:abstractText |
Peginterferon with ribavirin therapy for chronic hepatitis C leads to sustained loss of serum hepatitis C virus (HCV) RNA in half of treated patients. Although viral kinetic profiles in treatment responders shed light on the mechanism of action of interferon and ribavirin, minimal information is available to explain why some patients experience little or no virologic suppression.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/M01RR-00042,
http://linkedlifedata.com/resource/pubmed/grant/M01RR-00043,
http://linkedlifedata.com/resource/pubmed/grant/M01RR-00051,
http://linkedlifedata.com/resource/pubmed/grant/M01RR-00065,
http://linkedlifedata.com/resource/pubmed/grant/M01RR-00633,
http://linkedlifedata.com/resource/pubmed/grant/M01RR-00827,
http://linkedlifedata.com/resource/pubmed/grant/M01RR-01066,
http://linkedlifedata.com/resource/pubmed/grant/M01RR-06192,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2318,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2319,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2320,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2321,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2322,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2323,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2324,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2325,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2326,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2327,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2328
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1542-7714
|
pubmed:author |
pubmed-author:BonkovskyHerbert LHL,
pubmed-author:DienstagJules LJL,
pubmed-author:EversonGregory TGT,
pubmed-author:GhanyMarc GMG,
pubmed-author:Joint Commission of Accreditation of Healthcare Organizations,
pubmed-author:LeeWilliam MWM,
pubmed-author:LindsayKaren LKL,
pubmed-author:LokAnna S FAS,
pubmed-author:MorganTimothy RTR,
pubmed-author:MorishimaChihiroC,
pubmed-author:ShiffmanMitchell LML,
pubmed-author:WrightElizabeth CEC
|
pubmed:issnType |
Electronic
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
234-41
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:18237873-Ethnic Groups,
pubmed-meshheading:18237873-Female,
pubmed-meshheading:18237873-Genotype,
pubmed-meshheading:18237873-Hepacivirus,
pubmed-meshheading:18237873-Hepatitis C, Chronic,
pubmed-meshheading:18237873-Humans,
pubmed-meshheading:18237873-Interferon-alpha,
pubmed-meshheading:18237873-Leukopenia,
pubmed-meshheading:18237873-Male,
pubmed-meshheading:18237873-Middle Aged,
pubmed-meshheading:18237873-Polyethylene Glycols,
pubmed-meshheading:18237873-RNA, Viral,
pubmed-meshheading:18237873-Recombinant Proteins,
pubmed-meshheading:18237873-Ribavirin,
pubmed-meshheading:18237873-Thrombocytopenia,
pubmed-meshheading:18237873-Treatment Outcome,
pubmed-meshheading:18237873-Viral Load,
pubmed-meshheading:18237873-Weight Loss
|
pubmed:year |
2008
|
pubmed:articleTitle |
Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C.
|
pubmed:affiliation |
Division of Gastrointestinal and Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA. klindsay@usc.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|